Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3496501rdf:typepubmed:Citationlld:pubmed
pubmed-article:3496501lifeskim:mentionsumls-concept:C0278996lld:lifeskim
pubmed-article:3496501lifeskim:mentionsumls-concept:C0229664lld:lifeskim
pubmed-article:3496501lifeskim:mentionsumls-concept:C0014876lld:lifeskim
pubmed-article:3496501lifeskim:mentionsumls-concept:C0806987lld:lifeskim
pubmed-article:3496501lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:3496501pubmed:issue1lld:pubmed
pubmed-article:3496501pubmed:dateCreated1987-7-28lld:pubmed
pubmed-article:3496501pubmed:abstractTextWe show a significantly decreased number of OKT3+ lymphocytes in the peripheral blood (PB) of cancer patients mainly due to a reduced number of OKT4 cells. OKT8 cells were also somewhat reduced. The numbers of DR+ and interleukin-2 receptor-bearing T-cells were significantly increased in patients. The tumor-infiltrating cells included OKT4+ AND OKT8+ lymphocytes. There was a significant correlation between the proportion of activated T-cells in PB and in tumor, as shown by DR and interleukin-2 receptor expression.lld:pubmed
pubmed-article:3496501pubmed:languageenglld:pubmed
pubmed-article:3496501pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3496501pubmed:citationSubsetIMlld:pubmed
pubmed-article:3496501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3496501pubmed:statusMEDLINElld:pubmed
pubmed-article:3496501pubmed:issn0736-0118lld:pubmed
pubmed-article:3496501pubmed:authorpubmed-author:YouinouPPlld:pubmed
pubmed-article:3496501pubmed:authorpubmed-author:CharlesJ FJFlld:pubmed
pubmed-article:3496501pubmed:authorpubmed-author:Lozac'hPPlld:pubmed
pubmed-article:3496501pubmed:authorpubmed-author:CorbeauPPlld:pubmed
pubmed-article:3496501pubmed:authorpubmed-author:ZabbeCClld:pubmed
pubmed-article:3496501pubmed:issnTypePrintlld:pubmed
pubmed-article:3496501pubmed:volume4lld:pubmed
pubmed-article:3496501pubmed:ownerNLMlld:pubmed
pubmed-article:3496501pubmed:authorsCompleteYlld:pubmed
pubmed-article:3496501pubmed:pagination7-10lld:pubmed
pubmed-article:3496501pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:meshHeadingpubmed-meshheading:3496501-...lld:pubmed
pubmed-article:3496501pubmed:year1987lld:pubmed
pubmed-article:3496501pubmed:articleTitlePeripheral blood and tumor-infiltrating mononuclear cell analysis in esophagus and head and neck cancer.lld:pubmed
pubmed-article:3496501pubmed:publicationTypeJournal Articlelld:pubmed